Compulsory Licensing in Pharma Patents: A Win-Win Solution or a threat to innovation?
Is compulsory licensing in pharma patents the key to affordable medicines or a roadblock to innovation? This blog tackles this contentious debate, examining past cases, the WTO's TRIPS Agreement, and the impact on global health using AI patent search and